3Gerd Egger,Astrid Burda,Andrea Obernosterer,Heike Mitterhammer,Gerd Kager,Günther Jürgens,Herwig Peter Hofer,Judith S. Fabjan,Ernst Pilger. Blood Polymorphonuclear Leukocyte Activation in Atherosclerosis: Effects of Aspirin[J] 2001,Inflammation(2):129～135
二级参考文献24
1Hunt SC, Kronenberg F, Eckfeldt JH,et al.Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a ma-jor gene trait: the NHLBI family heart study.Atherosclerosis 2001;154(3):747-54.
2Asad SF,Singh S,Ahmad A,et al.Prooxidant and antioxidant activi-ties of bilirubin and its metabolic precursor biliverdin:a structure-activity study. Chem Biol Interact 2001;137(1):59-74.
3Wiesel P, Patel AP, Carvajal IM,et al.Exacerbation of chronic reno-vascular hypertension and acute renal failure in heme oxygenase-l-defi-cient mice. Circ Res 2001;88(10):1088-94.
4Siow RC, Sato H,Mann GE.Heme oxygenase-carbon monoxide sig-nalling pathway in atherosclerosis:anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 1999;41(2):385-94.
5Elbirt KK, Bonkovsky HL.Heme oxygenase: recent advances in under-standing its regulation and role.Proc Assoc Am Physicians 1999;111(5):438-47.
6Schwertner HA, Jackson WG, Tolan G. Association of low serum con-centration of bilirubin with increased risk of coronary artery disease. Clin Chem.1994 ;40(1):18-23.
7Mayer M.Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000;46(11):1723-7.
8Nakayama M, Takahashi K, Komaru T, et al.Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions.Arterioscler Thromb Vasc Biol 2001;21(8):1373-7.
9Johnson RA, Kozma F, Colombari E. Carbon monoxide: from toxin to endogenous modulator of cardiovascular functions. Braz. J Med Biol Res 1999;32(1):1-14.
10Djousse L, Levy D, Cupples LA,et al.Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study.Am J Cardiol 2001;87(10):1196-200.
3Mahmoud MS, Asmaa SA, Nahed AA.The reliability of the National Cholesterol Education Program's Adult Treatment Panel Ⅲ (NCEP/ATP Ⅲ)and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians[J]. Diabetes Metab Syndr, 2012, 6(1):4-8.
